Quantitative reverse transcription-polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features
about
sameAs
Markers of small cell lung cancerOrigins, genetic landscape, and emerging therapies of small cell lung cancerMolecular pathways and therapeutic targets in lung cancerDNA copy number alterations and PPARG amplification in a patient with multifocal bladder urothelial carcinoma.Generation of HIV-1 and Internal Control Transcripts as Standards for an In-House Quantitative Competitive RT-PCR Assay to Determine HIV-1 Viral LoadMatrilysin-1 mediates bronchiolization of alveoli, a potential premalignant change in lung cancer.Selective tropism of Seneca Valley virus for variant subtype small cell lung cancer.Neuroendocrine cancer-specific up-regulating mechanism of insulin-like growth factor binding protein-2 in small cell lung cancer.Sphingosine 1-phosphate receptor expression profile and regulation of migration in human thyroid cancer cells.Reliable transcript quantification by real-time reverse transcriptase-polymerase chain reaction in primary neuroblastoma using normalization to averaged expression levels of the control genes HPRT1 and SDHA.[Expression and clinicopathologic significance of human achaete-scute homolog 1 in pulmonary neuroendocrine tumors].Transcriptional deregulation underlying the pathogenesis of small cell lung cancer.Identification of candidate genes or microRNAs associated with the lymph node metastasis of SCLC
P2860
Q24798523-0F35330A-AF9A-44D4-8E19-03B596F0BC47Q26798218-DC241264-C579-4EFC-A8B6-00595377E8B8Q33688872-8888A4FA-DFAA-4FA8-96F3-8EAB17D40784Q34463194-F9D8D5CD-2367-4671-9838-06CD85A8CEAFQ35101414-BE05FE1B-CEF8-4CAF-87D9-FB98F63CB37FQ37278448-580B6ACA-8C9D-4C85-837F-A027915ECCCEQ37463325-3CFE84B8-A0F5-4EF1-B4B6-7938C7DB3AA6Q39812863-E4F1B39C-99D3-4515-931F-E1E842CB2726Q40271531-F3A41113-5DDB-442E-AA91-C09F44B273BCQ42141923-0A2FB18A-7B3C-4BC8-8F98-4AE3B869C954Q54417282-011754AE-4F7B-4326-9C20-D16463538BCAQ55011897-285FDC79-D302-4774-9C3D-7EB408231289Q58586691-A7CF06B9-2500-443E-B825-5396B2925413
P2860
Quantitative reverse transcription-polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features
description
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2002
@ast
im April 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: April 2002)
@en
vedecký článok (publikovaný 2002-04)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd in 2002-04)
@nl
наукова стаття, опублікована у квітні 2002
@uk
مقالة علمية (نشرت في أبريل 2002)
@ar
name
Quantitative reverse transcrip ...... s with neuroendocrine features
@ast
Quantitative reverse transcrip ...... s with neuroendocrine features
@en
Quantitative reverse transcrip ...... s with neuroendocrine features
@nl
type
label
Quantitative reverse transcrip ...... s with neuroendocrine features
@ast
Quantitative reverse transcrip ...... s with neuroendocrine features
@en
Quantitative reverse transcrip ...... s with neuroendocrine features
@nl
prefLabel
Quantitative reverse transcrip ...... s with neuroendocrine features
@ast
Quantitative reverse transcrip ...... s with neuroendocrine features
@en
Quantitative reverse transcrip ...... s with neuroendocrine features
@nl
P2093
P1476
Quantitative reverse transcrip ...... s with neuroendocrine features
@en
P2093
Ankie Poutsma
Bart A Westerman
Cees B M Oudejans
Inge J van Wijk
Monique Egging
Roderick H J Breuer
Sari Neijenhuis
P304
P407
P577
2002-04-01T00:00:00Z